BACKGROUND: It has been speculated that gender differences in cardiovascular disease (CVD) mortality can be attributed to the effects of estrogens on inflammation and hemostatic marker profiles. Therefore, we evaluated endogenous hormone concentrations, menopause transition stages, and adoption of exogenous hormone use in relation to hemostatic and inflammation marker concentrations in women. METHODS: Longitudinally, we… Continue reading Hemostatic factors and estrogen during the menopausal transition
Keyword:
The value of follicle-stimulating hormone concentration and clinical findings as markers of the late menopausal transition
CONTEXT: The Stages of Reproductive Aging Workshop proposed bleeding and hormonal criteria for the menopausal transition, but operational definitions of hormone parameters were not specified. OBJECTIVE: This paper investigates the longitudinal relationship of annual serum FSH levels with four proposed bleeding criteria for the late menopausal transition in two cohort studies. The goal is to… Continue reading The value of follicle-stimulating hormone concentration and clinical findings as markers of the late menopausal transition